Brandon Meyers(@BrandonMeyersMD) 's Twitter Profileg
Brandon Meyers

@BrandonMeyersMD

GI/HN ONC | RT=RT | 🚫 medical advice, my opine, dictated/not read, fierce advocate | dad jokes, 🚵‍♀️ https://t.co/msOPYkQBiJ

ID:1108496026128842752

calendar_today20-03-2019 22:30:22

7,3K Tweets

824 Followers

395 Following

Raghu Venugopal MD(@raghu_venugopal) 's Twitter Profile Photo

How Epic can slow MDs down. Complex patients do need a look at their medical record, but the most important is the bedside assessment. A typical Epic work-flow is:
1) dictate key parts of triage note into your note
2) open Health Connect Ontario for salient history
3) look at…

account_circle
C.D. McNaughton(@NashvegasEM) 's Twitter Profile Photo

Raghu Venugopal MD Salt in the wound: epic and the other big EHRs (xcept CPRS) are just glorified accounting systems - US accounting systems! 🤦🏼‍♀️

Do they really help us or pts in Canada? Unless used for system level QI or research, what value to they add?? 😭

account_circle
Najib Ben Khaled(@N_BenKhaled) 's Twitter Profile Photo

Read our paper in JHEP Reports on the risk of bleeding and thromboembolism in atezobev vs lenvatinib for HCC. Big thanks to the fantastic collaborators!

account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

Multicentre phs II trial of cabozantinib in HCC after immune checkpoint inhibitors
Journal of Hepatology
doi.org/10.1016/j.jhep…
🧐Efficacy of Cabozantinib in 2nd line after ICI, but disappointing data in 3rd line
ESMO - Eur. Oncology Milca Malary EASL Education

Multicentre phs II trial of cabozantinib in HCC after immune checkpoint inhibitors @JHepatology doi.org/10.1016/j.jhep… 🧐Efficacy of Cabozantinib in 2nd line after ICI, but disappointing data in 3rd line @myESMO @ilca @EASLedu #livertwitter
account_circle
Courtney(@ccoschi) 's Twitter Profile Photo

Congratulations!! I am so incredibly lucky to be mentored by Dr. Juergens-- there is no one more deserving of this award!

account_circle
Bijoy Telivala(@BijoyTelivala) 's Twitter Profile Photo

All cancer treatments unfortunately have some kind of acute & delayed side effects

Telling patient that there is NO SIDE EFFECTS is a blatant lie !!!

account_circle
Brandon Meyers(@BrandonMeyersMD) 's Twitter Profile Photo

No interest in family medicine?

Sure 🇨🇦 tax changes and longer residency will surely help!

Oh, and a special, a new not yet failure of a med school ⁦York University⁩. Great plans all around!

apple.news/ARCo_9li_SxaHQ…

account_circle
Sameer Parpia(@ParpiaSameer) 's Twitter Profile Photo

📢 (Bio)statistician Job Opportunity

We are seeking an enthusiastic (bio)statistician to join our biostatistics unit to support high quality, multi-centre clinical trials. To apply or view more details, please visit:

careers.mcmaster.ca/psp/prepprd/EM…

account_circle
Rick MaskDonald MD 🚴‍♂️🏄🏻🎾(@Kidsdoc1Rick) 's Twitter Profile Photo

I don’t understand this.
Has this been refused?

Are we now at the point that kids who need specialized consultations are now being declined because of waiting times?

Also,
• I never refer needlessly.
• This is also one of your expatients.
• additional information was sent!

I don’t understand this. Has this been refused? Are we now at the point that kids who need specialized consultations are now being declined because of waiting times? Also, • I never refer needlessly. • This is also one of your expatients. • additional information was sent!
account_circle
Raghu Venugopal MD(@raghu_venugopal) 's Twitter Profile Photo

Some analysis from a caring, expert, highly-respected MD:
-'As an incorporated MD you pay the new capital gains tax rate on the first dollar of capital gains earned. the 250K threshold applies only to individuals ie. non-MPCs'
-'this is very bad for all doctors who counted on…

account_circle
Pashtoon Kasi MD, MS(@pashtoonkasi) 's Twitter Profile Photo

💡Timing⏱️of assessing response to matters.

We underestimate how quickly immunotherapy works.👇🏾1️⃣2️⃣days with BOT/BAL 🪺all you see are immune cells🟣🟣in the biopsy.

At surgery➡️tumor is💯% dead; immune cells have left the party.

📸 RareCyte, Inc.

💡Timing⏱️of assessing response to #immunotherapy matters. We underestimate how quickly immunotherapy works.👇🏾1️⃣2️⃣days with BOT/BAL #NestTrial🪺all you see are immune cells🟣🟣in the biopsy. At surgery➡️tumor is💯% dead; immune cells have left the party. 📸 @RareCyte #CRCSM
account_circle
Dr. Nancy Olivieri(@DrNancyOlivieri) 's Twitter Profile Photo

Fiction: FDA 'accelerated approval' helps 'get drugs for serious unmet medical needs to patients sooner.'
Fact: Half of *cancer* drugs thus approved do not improve survival OR quality of life.
Pharma is, unsurprisingly, pleased with this:
statnews.com/2024/04/07/can…

account_circle
Cheryl White(@LadyScorcher) 's Twitter Profile Photo

Health task force blasted over ‘dangerous guidance’ for cancer screenings

They absolutely should be blasted. The dogmatic pursuit of RCTs and RCTs only is ignoring more recent and relevant science. Canadians are suffering and dying. globalnews.ca/news/10423697/…

account_circle